Term Name: pirtobrutinib
Synonyms: 5-amino-3-{4-[(5-fluoro-2-methoxybenzamido)methyl]phenyl}-1-[(2S)-1,1,1-trifluoropropan-2-yl]-1H-pyrazole-4-carboxamide, Jaypirca, LOXO 305, LOXO-305, LY 3527727, LY-3527727, LY3527727, pirtobrutinib, pirtobrutinibum, RXC-005, RXC005
Definition: A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-fluoro-2-methoxybenzoic acid with the amino group of 5-amino-3-[4-(aminomethyl)phenyl]-1-[(2S)-1,1,1-trifluoropropan-2-yl]-1H-pyrazole-4-carboxamide. It is a BTK inhibitor used for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Ontology: ChEBI [CHEBI:229212]  ( EBI )

Relationships
is a type of: benzamides monofluorobenzenes monomethoxybenzene organofluorine compound primary amino compound primary carboxamide pyrazoles secondary carboxamide
has_role: antineoplastic agent apoptosis inducer EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor